Stem Cell Research
MS Society Calls for Law Change on Unproven Stem Cell Trials
Published in Healthcare Finance, Tax and Law Weekly, December 17th, 2008
The MS Society supports the advice from the ISSCR that patients and their families should approach stem cell therapy with caution.
The Society has this week warned people with MS of a 'stem cell trial' being marketed from the Seychelles and Dubai, due to a lack of current evidence to support a stem cell treatment for MS.
It is understood that a company called Integrated BioSciences (IBS), registered in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AARP
AARP Tax-Aide Seeks Bilingual Volunteers for 2009 - Addiction Medicine
Researchers from Indiana University describe findings in addiction medicine - Addiction Medicine
Studies in the area of addiction medicine reported from S.M. Rosen and co-researchers - Allergies
Perrigo Settles Desloratadine Patent Litigation - America's Health Insurance Plans
Health Plans Offer Comprehensive Reform Proposal - American Legislative Exchange Council
Indiana Governor Mitch Daniels, Newt Gingrich, Amity Shlaes, U.S. Rep. Mary Fallin OK, U.S. Rep. Tom Price GA, and Others to Speak at National Gathering of State Legislators in Washington, D.C. - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
